Medicine and Dentistry
Liver Transplantation
100%
Hepatocellular Carcinoma
88%
Liver Cirrhosis
77%
Hepatitis C
55%
Liver Graft
38%
Hepatitis C Virus
32%
Cost-Effectiveness Analysis
31%
Transplantation
28%
Decompensated Liver Cirrhosis
27%
Liver Disease
25%
Prevalence
22%
Randomized Controlled Trial
20%
Boceprevir
20%
Hazard Ratio
20%
Ribavirin
19%
Adverse Event
17%
Hepatitis C Treatment
16%
Disease Management
16%
Chronic Disease
16%
Fibrosis
16%
Antiviral Drug
16%
Infection
15%
Neoplasm
15%
Nonalcoholic Fatty Liver
14%
Graft Survival
13%
Overall Survival
13%
Diseases
12%
Multivariate Analysis
12%
Health Care Cost
12%
Chronic Liver Disease
12%
Tumor Progression
12%
Peginterferon
11%
Nurse
11%
Alcohol Liver Disease
11%
Recurrent Disease
11%
Hepatitis B
11%
Radiation Therapy
10%
Adverse Outcome
10%
Varices
10%
Stereotactic Body Radiation Therapy
10%
Antiviral Therapy
9%
Treatment Response
9%
Chronic Hepatitis C
8%
Fatty Liver
8%
Tertiary Care
7%
Radiofrequency Ablation
7%
Hepatitis B Virus
6%
General Practitioner
6%
Systematic Review
6%
Diabetes
6%
Nursing and Health Professions
Liver Cirrhosis
39%
Hepatitis C
35%
Chronic Disease
24%
Disease Management
22%
Model of Care
18%
Liver Cell Carcinoma
17%
Cost Effectiveness Analysis
15%
Decompensated Liver Cirrhosis
14%
Self Care
13%
Prevalence
11%
Liver Failure
10%
Liver Transplantation
10%
Seroprevalence
10%
Retransplantation
10%
Point of Care Testing
10%
Antiviral Therapy
8%
Chronic Liver Disease
8%
Clinical Audit
7%
Confidence Interval
7%
General Practitioner
6%
Nurse Specialist
6%
Chronic Liver Failure
6%
Screening
5%
Practice Guideline
5%
Mental Health
5%
Diseases
5%
Propensity Score
5%
Vitamin D Deficiency
5%
Ribavirin
5%
Nurse Attitude
5%
Adverse Outcome
5%
Dasabuvir
5%
Paritaprevir
5%
Ombitasvir
5%
Ritonavir
5%
Daclatasvir
5%
Sofosbuvir
5%
Peginterferon
5%
Total Quality Management
5%
Primary Prevention
5%
Nurse-Led Clinics
5%
Esophagus Varices
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
40%
Hepatitis C
30%
Hepatitis C Virus
26%
Liver Cirrhosis
16%
Prevalence
15%
Boceprevir
15%
Neoplasm
11%
Seroprevalence
11%
Autoimmune Hepatitis
10%
Recurrent Disease
10%
Chronic Liver Failure
10%
Ribavirin
8%
Peginterferon
7%
Nonalcoholic Fatty Liver
7%
Overall Survival
6%
Adverse Event
6%
Tumor Growth
6%
Hepatitis C Virus Genotype 1
6%
Chronic Disease
5%
Tumor Necrosis
5%
Intestinal Permeability
5%
Endotoxemia
5%
Hepatitis A
5%
Adverse Outcome
5%
Osteodystrophy
5%
Hepatitis B
5%
Ombitasvir
5%
Paritaprevir
5%
Dasabuvir
5%
Daclatasvir
5%
Tacrolimus
5%
Fibrosis
5%
Intestine Tumor
5%
Mycophenolate Mofetil
5%
Antiviral Drug
5%
